Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 7.22MCash and Equivalents
VS
Market
Sector
Industry
History
$ 0.74Close
$ 0.68 - $ 4.73 52-Week Range
Ticker Information
Ticker
KTTACompany Name
PASITHEA THERAPEUTICS CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQPASITHEA THERAPEUTICS CORP - Cash and Equivalents Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
KTTA - CashnEq Historical data
| Date | Cash and Equivalents |
|---|---|
| 6/30/2025 | $ 7.22M |
| 3/31/2025 | $ 5.34M |
| 12/31/2024 | $ 6.92M |
| 9/30/2024 | $ 9.36M |
| 6/30/2024 | $ 7.97M |
| 3/31/2024 | $ 12.01M |
| 12/31/2023 | $ 16.33M |
| 9/30/2023 | $ 19.58M |
| 6/30/2023 | $ 26.65M |
| 3/31/2023 | $ 29.91M |
Key Performance Insights, Last 5 Years
- PASITHEA THERAPEUTICS CORP's latest trailing twelve months (TTM) CashnEq stands at $ 243.65K.
- Over the past 5 years, PASITHEA THERAPEUTICS CORP's average CashnEq has been $ 20.55M.
- The median CashnEq for PASITHEA THERAPEUTICS CORP during this period was $ 16.33M
- PASITHEA THERAPEUTICS CORP reached its highest CashnEq over the past 5 years at $ 52.97M.
- The lowest CashnEq recorded by PASITHEA THERAPEUTICS CORP in the same timeframe $ 243.65K
Similar metrics to CashnEq:
- Cash to Assets Ratio - [Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
- Net Cash Flow - Change in Cash & Cash Equivalents - [Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]
- Non-Current Assets - [Balance Sheet] The non-current (long-term) portion of [Assets] that are not easily converted to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
- Cash Ratio - [Calculation] The Cash Ratio is a liquidity indicator that describes a company's ability to meet short-term obligations with cash and cash equivalents. Calculated by dividing cash and cash equivalents [CashnEq] by current liabilities [LiabilitiesC].
- Current Assets - [Balance Sheet] The current (short-term) portion of [Assets] that are usually convertible to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
Definition of Cash and Equivalents
[Balance Sheet] Cash and cash equivalents are the sum of [Assets] that are cash or can be converted to cash in less than one year.KTTA - Cash and Equivalents, Last 5 years
$ 243.65K
Minimum
Dec 31, 2020
$ 52.97M
Maximum
Dec 31, 2021
$ 20.55M
Average
$ 16.33M
Median
CashnEq Benchmark AnalysisMarket
The chart above depicts the distribution of CashnEq for companies in the Total Stock Market. The average CashnEq of the companies is $ 99.33M with a standard deviation of $ 119.9M.
The following table provides additional summary stats:
CashnEq in the Market:
| filtered constituents | 3.61K |
|---|---|
| min | $ 0 |
| max | $ 495M |
| average | $ 99.33M |
| median | $ 48.36M |
| std | $ 119.9M |